$HIPH "There are currently more distribution deals in the pipeline for other countries, but in the interim, the new 1oz version is now available for sale at a lower price point, opening the door for exposure to a different customer base that should increase visibility and sales. Vanexxe is a revolutionary product that cosmetically addresses painful and unsightly varicose veins; there is nothing on the market that fulfills this need at the price point and efficacy of Vanexxe.” -CEO Ryan Fishoff commented
“While the Company continues to focus on expanding distribution of all its brands and products, the recent COVID-19 (Coronavirus) outbreak has changed the retail climate. I don’t think there is any way to escape it. The key for the Company is to mitigate its impact on our continued efforts to expand distribution and increase sales. Launching our new products (100mg shots and CBD flavored water) remains a top priority. The Company received excellent feedback on these products at the CBD Expo and Champs Trade show. Numerous retailers and distributors expressed interest in placing orders. Recent events have paused the retail launch of these products. The Company continues to monitor the situation on ground. As it becomes clearer when things will return to normal, we will decide when the right time will be to launch the product in a proper manner. In the interim, we will focus on platforms like Walmart.com, Amazon, and other online channels which are currently seeing large increases in traffic.
“I do feel that the Company has a corporate and social responsibility to help in the effort to combat Coronavirus. I was quite moved by what LVMH did by switching their fragrance production line to produce hand sanitizer that will be distributed to the French population to help combat the spread of the virus. I am exploring ways that the Company can help and participate in the greater efforts to control this virus. We are evaluating ways that we can contribute to the cause without the Company deviating from its business plan. Under consideration is how we could potentially leverage our Hydro-Nano technology to create sanitizer products that could be more effective and efficient in eliminating germs. We are also exploring if our Hydro-Nano technology, combined with CBD, could, in any way, be helpful in treating the virus. I caution that there are so many unknowns at this juncture, but I do believe that it’s in the best interests of the Company to help contribute in the global fight against this pandemic, which ultimately I believe will be in the shareholders interest. I look forward to sharing progress with investors and the shareholder community in the coming weeks about our product launch initiatives and our contribution to the fight against the spread of Coronavirus,” concluded Mr. Fishoff
“While the Company continues to focus on expanding distribution of all its brands and products, the recent COVID-19 (Coronavirus) outbreak has changed the retail climate. I don’t think there is any way to escape it. The key for the Company is to mitigate its impact on our continued efforts to expand distribution and increase sales. Launching our new products (100mg shots and CBD flavored water) remains a top priority. The Company received excellent feedback on these products at the CBD Expo and Champs Trade show. Numerous retailers and distributors expressed interest in placing orders. Recent events have paused the retail launch of these products. The Company continues to monitor the situation on ground. As it becomes clearer when things will return to normal, we will decide when the right time will be to launch the product in a proper manner. In the interim, we will focus on platforms like Walmart.com, Amazon, and other online channels which are currently seeing large increases in traffic.
“I do feel that the Company has a corporate and social responsibility to help in the effort to combat Coronavirus. I was quite moved by what LVMH did by switching their fragrance production line to produce hand sanitizer that will be distributed to the French population to help combat the spread of the virus. I am exploring ways that the Company can help and participate in the greater efforts to control this virus. We are evaluating ways that we can contribute to the cause without the Company deviating from its business plan. Under consideration is how we could potentially leverage our Hydro-Nano technology to create sanitizer products that could be more effective and efficient in eliminating germs. We are also exploring if our Hydro-Nano technology, combined with CBD, could, in any way, be helpful in treating the virus. I caution that there are so many unknowns at this juncture, but I do believe that it’s in the best interests of the Company to help contribute in the global fight against this pandemic, which ultimately I believe will be in the shareholders interest. I look forward to sharing progress with investors and the shareholder community in the coming weeks about our product launch initiatives and our contribution to the fight against the spread of Coronavirus,” concluded Mr. Fishoff
